A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 23,101 shares of REGN stock, worth $16.7 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
23,101
Previous 23,298 0.85%
Holding current value
$16.7 Million
Previous $24.5 Million 0.82%
% of portfolio
0.16%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1024.09 - $1201.76 $201,745 - $236,746
-197 Reduced 0.85%
23,101 $24.3 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $93,619 - $113,546
106 Added 0.46%
23,298 $24.5 Million
Q1 2024

May 08, 2024

SELL
$902.69 - $993.35 $241,920 - $266,217
-268 Reduced 1.14%
23,192 $22.3 Million
Q4 2023

Feb 09, 2024

BUY
$775.18 - $881.7 $1.55 Million - $1.76 Million
1,998 Added 9.31%
23,460 $20.6 Million
Q3 2023

Nov 09, 2023

BUY
$692.45 - $844.37 $1.83 Million - $2.23 Million
2,645 Added 14.06%
21,462 $17.7 Million
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $414,417 - $491,567
592 Added 3.25%
18,817 $13.5 Million
Q1 2023

May 09, 2023

BUY
$680.49 - $826.97 $84,380 - $102,544
124 Added 0.69%
18,225 $15 Million
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $1.71 Million - $1.86 Million
2,422 Added 15.45%
18,101 $13.1 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $28,698 - $36,216
-50 Reduced 0.32%
15,679 $10.8 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $795,107 - $1.07 Million
1,450 Added 10.15%
15,729 $9.3 Million
Q1 2022

May 12, 2022

BUY
$595.12 - $698.43 $600,476 - $704,715
1,009 Added 7.6%
14,279 $9.97 Million
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $53,261 - $65,755
98 Added 0.74%
13,270 $8.38 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $31,571 - $37,452
55 Added 0.42%
13,172 $7.97 Million
Q2 2021

Aug 12, 2021

SELL
$472.8 - $558.54 $23,640 - $27,927
-50 Reduced 0.38%
13,117 $7.33 Million
Q1 2021

May 12, 2021

BUY
$446.73 - $548.2 $29,037 - $35,633
65 Added 0.5%
13,167 $6.23 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $1.63 Million - $2.08 Million
3,416 Added 35.27%
13,102 $6.33 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $2.13 Million - $2.58 Million
3,918 Added 67.93%
9,686 $5.42 Million
Q2 2020

Aug 11, 2020

BUY
$493.32 - $643.92 $328,057 - $428,206
665 Added 13.03%
5,768 $3.6 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $13,783 - $20,271
-41 Reduced 0.8%
5,103 $2.49 Million
Q4 2019

Feb 11, 2020

BUY
$274.13 - $376.51 $6,579 - $9,036
24 Added 0.47%
5,144 $1.93 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $137,550 - $160,150
503 Added 10.89%
5,120 $1.42 Million
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $10,486 - $14,518
35 Added 0.76%
4,617 $1.45 Million
Q1 2019

May 07, 2019

BUY
$372.08 - $439.57 $129,483 - $152,970
348 Added 8.22%
4,582 $1.88 Million
Q4 2018

Feb 11, 2019

SELL
$335.82 - $403.04 $713,617 - $856,460
-2,125 Reduced 33.42%
4,234 $1.58 Million
Q3 2018

Nov 08, 2018

SELL
$351.14 - $408.51 $609,930 - $709,581
-1,737 Reduced 21.46%
6,359 $2.57 Million
Q2 2018

Aug 03, 2018

BUY
$284.6 - $344.99 $337,535 - $409,158
1,186 Added 17.16%
8,096 $2.79 Million
Q1 2018

May 09, 2018

BUY
$315.82 - $393.78 $6,000 - $7,481
19 Added 0.28%
6,910 $2.38 Million
Q4 2017

Feb 13, 2018

BUY
$358.63 - $469.95 $230,599 - $302,177
643 Added 10.29%
6,891 $2.59 Million
Q3 2017

Nov 09, 2017

BUY
$431.38 - $504.0 $2.7 Million - $3.15 Million
6,248
6,248 $2.79 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.